Deep Track Capital, LP 13D and 13G filings for Autolus Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 09:12 am Purchase |
2024-09-30 | 13G | Autolus Therapeutics plc AUTL |
Deep Track Capital, LP | 15,272,172 5.740% |
3,402,875 (+28.67%) |
Filing |
| 2024-02-14 08:37 am Sale |
2023-12-31 | 13G | Autolus Therapeutics plc AUTL |
Deep Track Capital, LP | 11,869,297 6.820% |
-3,130,703 (-20.87%) |
Filing |
| 2023-02-14 08:30 am Unchanged |
2022-12-31 | 13G | Autolus Therapeutics plc AUTL |
Deep Track Capital, LP | 15,000,000 8.670% |
0 (Unchanged) |
Filing |
| 2022-12-19 4:11 pm Purchase |
2022-12-09 | 13G | Autolus Therapeutics plc AUTL |
Deep Track Capital, LP | 15,000,000 9.030% |
15,000,000 (New Position) |
Filing |